MedTrace Logo

Optimization of Initial Energy for Cardioversion of Atrial Fibrillation With Biphasic Shocks

NCT01910779 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 154

Last updated 2013-07-30

No results posted yet for this study

Summary

Use of higher energy doses (120-150 J) may not offer additional benefits and higher success rate compared with low to moderate initial energy (100-120 J) of biphasic shock for atrial fibrillation cardioversion. In this prospective open-label randomized trial consecutive patients with AF and candidate to AF electrical cardioversion will be randomized to receive 100J or 120 J as initial dose of biphasic shock. Patients will be also randomized in each group to anterolateral or postero-anteriore placement of defibrillator electrodes.

Conditions

Interventions

PROCEDURE

100 joule as first biphasic shock energy

PROCEDURE

120 joule as first biphasic shock energy

Sponsors & Collaborators

  • Maria Vittoria Hospital

    lead OTHER

Principal Investigators

  • Massimo Imazio, MD · Cardiology Dpt. Maria Vittoria Hospital, Torino, Italy

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2014-03-31
Completion
2014-04-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01910779 on ClinicalTrials.gov